VERTEX PHARMACEUTICALS ($VRTX) posted quarterly earnings results on Monday, February 10th. The company reported earnings of $3.98 per share, missing estimates of $4.11 by $0.13. The company also reported revenue of $2,912,000,000, beating estimates of $2,837,336,937 by $74,663,063.
You can see Quiver Quantitative's $VRTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
VERTEX PHARMACEUTICALS Insider Trading Activity
VERTEX PHARMACEUTICALS insiders have traded $VRTX stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $VRTX stock by insiders over the last 6 months:
- RESHMA KEWALRAMANI (CEO & President) sold 15,198 shares for an estimated $7,826,970
- JEFFREY M LEIDEN (Executive Chairman) sold 3,784 shares for an estimated $1,888,216
- JONATHAN BILLER (EVP and Chief Legal Officer) sold 999 shares for an estimated $461,198
- SANGEETA N. BHATIA sold 646 shares for an estimated $323,000
- DAVID ALTSHULER (EVP, Chief Scientific Officer) sold 15 shares for an estimated $7,178
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
VERTEX PHARMACEUTICALS Hedge Fund Activity
We have seen 654 institutional investors add shares of VERTEX PHARMACEUTICALS stock to their portfolio, and 789 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- PARNASSUS INVESTMENTS, LLC added 1,815,950 shares (+inf%) to their portfolio in Q4 2024, for an estimated $731,283,065
- EDGEWOOD MANAGEMENT LLC added 1,526,983 shares (+7876.3%) to their portfolio in Q3 2024, for an estimated $710,169,253
- JENNISON ASSOCIATES LLC removed 1,232,624 shares (-22.2%) from their portfolio in Q4 2024, for an estimated $496,377,684
- WCM INVESTMENT MANAGEMENT, LLC added 1,091,522 shares (+inf%) to their portfolio in Q4 2024, for an estimated $439,555,909
- WELLINGTON MANAGEMENT GROUP LLP added 704,421 shares (+17.2%) to their portfolio in Q3 2024, for an estimated $327,612,118
- GOLDMAN SACHS GROUP INC removed 703,965 shares (-34.1%) from their portfolio in Q3 2024, for an estimated $327,400,042
- VOYA INVESTMENT MANAGEMENT LLC removed 544,625 shares (-36.7%) from their portfolio in Q3 2024, for an estimated $253,294,195
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
